Jubilant Life Sciences reports 64% rise in Q2 consolidated net profit

22 Oct 2018 Evaluate

Jubilant Life Sciences has reported results for second quarter ended September 30, 2018.

The company has reported a rise of 39.96% in its net profit at Rs 79.61 crore for the quarter under review as compared to Rs 56.88 crore for the same quarter in the previous year. Total income of the company increased by 25.80% at Rs 951.07 crore for Q2FY19 as compared Rs 756.00 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 64.05% in its net profit at Rs 210.41 crore for the quarter under review as compared to Rs 128.26 crore for the same quarter in the previous year. Total income of the company increased by 37.85% at Rs 2,273.32 crore for Q2FY19 as compared Rs 1,649.13 crore for the corresponding quarter previous year.

Jubilant Pharmova Share Price

954.65 -13.60 (-1.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×